News - 03 Feb `20Emerging drugs for the treatment of vitiligo

New

Our co-authored paper titled Emerging drugs for the treatment of vitiligo has been published in the journal Expert Opinion on Emerging Drugs.

This study comprehensively summarizes the current concepts in the pathogenesis of vitiligo with special focus on the cytokine and signaling pathways, which are the targets for newer drugs. JAK kinase signaling pathways and the cytokines involved are the focus of vitiligo treatment in current research, followed by antioxidant and repigmenting mechanisms, basic fibroblast growth factors, afamelanotide and targeted immunotherapy.

For more information about emerging treatments for vitiligo, check out Drug Pipelines or Trials Hub sections of our website.

We also recommend reading our exclusive Vitiligo Drug Pipeline Analysis and Market Insights

 

      FAQOther Questions

      • What is vitiligo?

        Vitiligo (pronounced vit-ill-EYE-go) is a relatively common skin disease characterized by smooth, white, painless spots or patches on various parts of the body and hairs above i...

      • How to get insurance coverage for vitiligo treatments?

        Most of health insurance companies will initially reject claims for vitiligo doctor visits or phototherapy treatments but with enough efforts you can have a substantial part of ...

      • Can a gluten-free diet help with vitiligo?

        It's very unlikely. We have specifically looked into claims that gluten-free diet may ease symptoms of vitiligo, or completely reverse it, and found no firm scientific evidence ...